274 related articles for article (PubMed ID: 23769790)
1. Exacerbation of central serous chorioretinopathy following PASCAL photocoagulation.
Yang HS; Park SH
Can J Ophthalmol; 2013 Jun; 48(3):e42-3. PubMed ID: 23769790
[No Abstract] [Full Text] [Related]
2. Regression of serous macular detachment due to peripheral exudative hemorrhagic chorioretinopathy following intravitreal bevacizumab.
Barkmeier AJ; Kadikoy H; Holz ER; Carvounis PE
Eur J Ophthalmol; 2011; 21(4):506-8. PubMed ID: 21240857
[TBL] [Abstract][Full Text] [Related]
3. FLAT IRREGULAR PIGMENT EPITHELIUM DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: A Form of Pachychoroid Neovasculopathy?
Hwang H; Kim JY; Kim KT; Chae JB; Kim DY
Retina; 2020 Sep; 40(9):1724-1733. PubMed ID: 31584559
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab for choroidal neovascularization secondary to laser photocoagulation for central serous chorioretinopathy.
Pikkel J; Rumelt S
Eur J Ophthalmol; 2012; 22(3):488-91. PubMed ID: 21928270
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab injection for central serous chorioretinopathy.
Nowroozzadeh MH
Retina; 2010 Sep; 30(8):1322-3; author reply 1323. PubMed ID: 20827148
[No Abstract] [Full Text] [Related]
6. Intravitreal bevacizumab injection for central serous chorioretinopathy.
Chhablani JK; Narayanan R
Retina; 2010 Sep; 30(8):1323-24; author reply 1324. PubMed ID: 20661171
[No Abstract] [Full Text] [Related]
7. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab injection for central serous chorioretinopathy.
Lim SJ; Roh MI; Kwon OW
Retina; 2010 Jan; 30(1):100-6. PubMed ID: 20010322
[TBL] [Abstract][Full Text] [Related]
9. Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy.
Okamoto M; Matsuura T; Ogata N
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):25-32. PubMed ID: 25559505
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy.
Lee JY; Chae JB; Yang SJ; Kim JG; Yoon YH
Acta Ophthalmol; 2011 May; 89(3):e293-4. PubMed ID: 20346078
[No Abstract] [Full Text] [Related]
11. Results of one-year follow-up examinations after intravitreal bevacizumab administration for chronic central serous chorioretinopathy.
Inoue M; Kadonosono K; Watanabe Y; Kobayashi S; Yamane S; Arakawa A
Ophthalmologica; 2011; 225(1):37-40. PubMed ID: 20693820
[TBL] [Abstract][Full Text] [Related]
12. Treatment of macular serous neuroretinal detachment in tilted disk syndrome: report of 3 cases.
Donati MC; Miele A; Abbruzzese G; Giuntoli M; Giansanti F; Menchini U
Eur J Ophthalmol; 2013; 23(2):267-70. PubMed ID: 23225087
[TBL] [Abstract][Full Text] [Related]
13. Fibrovascular pigment epithelial detachment is a risk factor for long-term visual decay in neovascular age-related macular degeneretion.
Hoerster R; Muether PS; Sitnilska V; Kirchhof B; Fauser S
Retina; 2014 Sep; 34(9):1767-73. PubMed ID: 24936942
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy.
Schaal KB; Hoeh AE; Scheuerle A; Schuett F; Dithmar S
Eur J Ophthalmol; 2009; 19(4):613-7. PubMed ID: 19551677
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients.
Kim GA; Rim TH; Lee SC; Byeon SH; Koh HJ; Kim SS; Lee CS
Eye (Lond); 2015 Jun; 29(6):732-40; quiz 741. PubMed ID: 25952951
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy.
Ernst BJ; García-Aguirre G; Oliver SC; Olson JL; Mandava N; Quiroz-Mercado H
Acta Ophthalmol; 2012 Nov; 90(7):e573-4. PubMed ID: 22405048
[No Abstract] [Full Text] [Related]
17. Intravitreal bevacizumab for iatrogenic choroidal neovascularization due to laser photocoagulation in central serous chorioretinopathy.
Nomura Y; Obata R; Yanagi Y
Jpn J Ophthalmol; 2012 May; 56(3):245-9. PubMed ID: 22526618
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal aflibercept for choroidal neovascularisation complicating chronic central serous chorioretinopathy.
Broadhead GK; Chang A
Graefes Arch Clin Exp Ophthalmol; 2015 Jun; 253(6):979-81. PubMed ID: 25547617
[No Abstract] [Full Text] [Related]
19. Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study.
Artunay O; Yuzbasioglu E; Rasier R; Sengul A; Bahcecioglu H
Curr Eye Res; 2010 Feb; 35(2):91-8. PubMed ID: 20136418
[TBL] [Abstract][Full Text] [Related]
20. Choroidal detachment after PASCAL photocoagulation.
Natesh S; Ranganath A; Harsha K; Yadav NK; Bhujang BS
Can J Ophthalmol; 2011 Feb; 46(1):91. PubMed ID: 21283169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
